Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 217-315-6 | CAS number: 1809-14-9
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
Results of available in vitro studies:
- AMES test: negative.
- In Vitro Mammalian Chromosomal Aberration Test: negative.
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Genetic toxicity in vivo
Description of key information
No study available.
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
The genetic toxicity of Dioctyl phosphonate was investigated with different types of in vitro tests:
- AMES test: Dioctyl phosphonate was examined for the ability to induce gene mutations in tester strains of Salmonella typhimurium and Escherichia coli. The five tester strains TA1535, TA1537, TA98, TA100 and WP2 uvrA were used. Experiments were performed both in the absence and presence of metabolic activation, using liver S9 fraction from rats pre-treated with Phenobarbital and 5,6-benzoflavone. No increases in revertant numbers were observed, at any dose level, with any tester strain, in the absence or presence of S9 metabolic activation.
- In Vitro Mammalian Chromosomal Aberration Test: Dioctyl phosphonate was assessed for its potential to induce structural chromosome aberrations in V79 cells of the Chinese hamster in vitro in two independent experiments. The experiment was performed in 1997. The chromosomes were prepared 18 h and 28 h after start of treatment with the test article. The treatment interval was 4 h with metabolic activation, 18 h and 28 h without metabolic activation. In both independent experiments, there were no biologically relevant increases in cells carrying structural chromosome aberrations after treatment with the test article. In addition no increase in the frequencies of polyploid metaphases was found after treatment with the test article as compared to the frequencies of the controls. In conclusion, it can be stated that Dioctyl phosphonate did not induce structural chromosome aberrations in vitro.
Justification for classification or non-classification
Dioctyl phosphonate is not classified for genetic toxicity according to the CLP Regulation (EC.n.1272/2008). For justification see the results of available studies.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
